...
首页> 外文期刊>Haematologica >Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival | Haematologica
【24h】

Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival | Haematologica

机译:人骨髓瘤细胞中趋化因子受体(CCR1,CCR2和CXCR4)表达的临床意义:与疾病活性和生存的关系血液学

获取原文
           

摘要

BACKGROUND AND OBJECTIVES: The capacity of multiple myeloma (MM) cells to home to and reside in the bone marrow implies that they must be equipped with appropriate adhesion molecules and chemokine receptors to allow transendothelial migration. We and others have previously shown that human MM cells express at least three different chemokine receptors that are functionally involved in MM cell migration, i.e. CCR1, CCR2 and CXCR4. In this study, we analyzed the surface expression of these chemokine receptors on primary MM cells from bone marrow samples. DESIGN AND METHODS: Chemokine receptor expression was analyzed on bone marrow samples from a large population of patients (n=80) by flow cytometric analysis. The chemokine receptor expression profile was compared with clinical characteristics. Statistical significance was evaluated by Fisher's exact test. Survival curves were constructed using the Kaplan-Meier method. Cox regression analysis was used to determine the effect of chemokine receptor expression on survival. RESULTS: A heterogeneous expression pattern was observed for the three receptors tested. The chemokine receptor status (CRS) (i.e. no expression versus expression of at least one chemokine receptor), as well as expression of individual chemokine receptors was analyzed in relation to clinical and laboratory features and evaluated for prognostic significance. Chemokine receptor expression was significantly inversely correlated with disease activity: patients with active disease showed a significantly lower expression of CCR1, CCR2, as well as CXCR4 as compared to patients with non-active disease. Furthermore, the chemokine receptor expression profile correlated with serum beta2-microglobulin, C-reactive protein and hemoglobin. CRS, and the individual expressions of CCR1, CCR2 and CXCR4 in diagnostic bone marrow samples (n=70) correlated with survival. Multivariate analysis, using the Cox proportional hazard regression model, identified CRS, along with serum beta-microglobulin, as an independent prognostic factor. INTERPRETATION AND CONCLUSIONS: This study indicates that the chemokine receptor expression profile of MM cells correlates with disease status and survival of MM patients. This observation might reflect impaired chemoattraction and retention of MM cells within the bone marrow microenvironment, resulting in disease progression.
机译:背景与目的:多发性骨髓瘤(MM)细胞能够归巢并驻留于骨髓中的能力意味着它们必须配备适当的粘附分子和趋化因子受体,以允许跨内皮迁移。我们和其他人先前已经表明,人类MM细胞表达至少三种功能上与MM细胞迁移有关的趋化因子受体,即CCR1,CCR2和CXCR4。在这项研究中,我们分析了这些趋化因子受体在来自骨髓样本的原代MM细胞上的表面表达。设计与方法:通过流式细胞术分析了来自大量患者(n = 80)的骨髓样本中的趋化因子受体表达。将趋化因子受体表达谱与临床特征进行比较。统计显着性通过Fisher精确检验进行评估。使用Kaplan-Meier方法构建生存曲线。使用Cox回归分析来确定趋化因子受体表达对生存的影响。结果:观察到三种受体的异质表达模式。结合临床和实验室特征分析趋化因子受体状态(CRS)(即无一种趋化因子的表达与至少一种趋化因子受体的表达)以及个别趋化因子受体的表达,并评估其预后意义。趋化因子受体的表达与疾病活动性呈显着负相关:活动性疾病患者与非活动性疾病患者相比,CCR1,CCR2和CXCR4的表达显着降低。此外,趋化因子受体的表达谱与血清β2-微球蛋白,C反应蛋白和血红蛋白相关。 CRS以及诊断性骨髓样本(n = 70)中CCR1,CCR2和CXCR4的个别表达与生存率相关。使用Cox比例风险回归模型进行的多变量分析将CRS与血清β-微球蛋白一起确定为独立的预后因素。解释和结论:这项研究表明,MM细胞趋化因子受体的表达谱与MM患者的疾病状态和存活率有关。该观察结果可能反映了趋化性受损和MM细胞在骨髓微环境中的滞留,导致疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号